1. Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs
   Jun Zhang et al, 2016, American Journal of Physiology-Cell Physiology CrossRef
2. Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
   Mazen Kreidy et al, 2020, BMC Pulmonary Medicine CrossRef
3. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats
   Ruizan Shi et al, 2018, Pulmonary Pharmacology & Therapeutics CrossRef
4. An integrative review of nonobvious puzzles of cellular and molecular cardiooncology
   Paweł Uruski et al, 2023, Cellular & Molecular Biology Letters CrossRef
5. B-cells in pulmonary arterial hypertension: friend, foe or bystander?
   Sébastien Sanges et al, 2024, European Respiratory Journal CrossRef
6. Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB)
   Yuanshi Li et al, 2018, Cardiovascular Pathology CrossRef
7. Co-operative Research on Financing Ecological and Efficiency of Industrial—Evidence from China’s New Energy Industry
   Hairong Wang et al, 2022, Mathematical Problems in Engineering CrossRef
8. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response
   Yun Luan et al, 2015, International Immunopharmacology CrossRef
9. Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions
   I-Chen Chen et al, 2022, Biomedicines CrossRef
10. Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway
    Zhaohua Zhang et al, 2017, Oncotarget CrossRef